Natco Pharma’s Vizag plant begins production

Our Bureau Hyderabad | Updated on November 14, 2019

Natco Pharma Ltd’s finished dosage formulations (FDF) facility in Visakhapatnam has commenced commercial operations.

The facility is a part of the Special Economic Zone (SEZ) and is intended to cater primarily to the US and other international markets.

“The Vizag facility is a key part of NATCO' s capacity expansion plans for its pipeline of products and entry into new geographies. The facility will focus on oral solid dosages (tablets and capsules), including a cytotoxic block for products in the oncology segment,’’ the Hyderabad-based company said in a release.

An application had been filed with the US Food and Drug Administration (USFDA) for site transfer of the first product and to trigger a regulatory audit, it added.

Natco’s scrip ended flat on the Bombay Stock Exchange on Thursday at Rs 599.40.

Published on November 14, 2019

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like